PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Surgery and Dentistry, \'Scuola Medica Salernitana\', Unit of Infectious Diseases, University of Salerno, Baronissi, Italy.\', \'Department of Medicine, Surgery and Dentistry, \'Scuola Medica Salernitana\', Unit of Pharmacology, University of Salerno, Baronissi, Italy.\', \'Department of Medicine, Surgery and Dentistry, \'Scuola Medica Salernitana\', Unit of Anesthesiology, University of Salerno, Baronissi, Italy.\', \'Department of Medicine, Service of Infectious Diseases, Cardarelli Hospital, Naples, Italy.\', \'Department of Medicine, Surgery and Dentistry \'Scuola Medica Salernitana\', Unit of Microbiology, University of Salerno, Baronissi, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/17460441.2021.1970743
?:hasPublicationType
?:journal
  • Expert opinion on drug discovery
is ?:pmid of
?:pmid
?:pmid
  • 34412564
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.309
?:rankingScore_hIndex
  • 46
is ?:relation_isRelatedTo_publication of
?:title
  • An overview of the preclinical discovery and development of remdesivir for the treatment of coronavirus disease 2019 (COVID-19).
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34412564>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34412564>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all